Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Lise-Lotte Olsson
Based on 3 articles published since 2010
(Why 3 articles?)
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 3 published articles on Alzheimer Disease from 2010 through 2020, it is not possible for Expertscape to reliably rate Lise-Lotte Olsson's expertise on this topic.

Work Locations
Details
Most likely:    AstraZeneca      
2014
  • Antibody Discovery and Protein Engineering, MedImmune, Cambridge, United Kingdom. · Discovery Sciences, AstraZeneca R & D, Mölndal, Sweden. · Global Drug Discovery, Global Biologics, Bayer HealthCare AG, Cologne, Germany. · CNS&P iMed, AstraZeneca R & D, Södertälje, Sweden. · Pubmed 25089527
2012
  • Innovative Medicines AstraZeneca, CNS and Pain, 15185 Södertälje, Sweden. · Pubmed 23048024
  • Department of Medicinal Chemistry, AstraZeneca R&D Södertälje, SE-15185 Södertälje, Sweden. · Pubmed 22325942
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Lise-Lotte Olsson in 2010-2020 about Alzheimer Disease:

  • Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease. 2014
  • Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease. 2012
  • Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy. 2012
Show List of Full Article Records
Google Searches

Learn more about Lise-Lotte Olsson using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
AstraZeneca
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
AstraZeneca
2014
  • Antibody Discovery and Protein Engineering, MedImmune, Cambridge, United Kingdom. · Discovery Sciences, AstraZeneca R & D, Mölndal, Sweden. · Global Drug Discovery, Global Biologics, Bayer HealthCare AG, Cologne, Germany. · CNS&P iMed, AstraZeneca R & D, Södertälje, Sweden. · Pubmed 25089527
2012
  • Innovative Medicines AstraZeneca, CNS and Pain, 15185 Södertälje, Sweden. · Pubmed 23048024
  • Department of Medicinal Chemistry, AstraZeneca R&D Södertälje, SE-15185 Södertälje, Sweden. · Pubmed 22325942
Yearly article counts 00000010200
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.